Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117779063A reveals metal-free electrochemical synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101328143B reveals a safe Cu-catalyzed route for difluoromethyl sulfoximines, offering significant cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Novel copper-catalyzed method for N-sulfonyl sulfoximine derivatives. High yield, scalable process for pharmaceutical intermediates supply chain.
Patent CN114381441B reveals imine reductase catalysis for optical pure chiral amino alcohols. Offers mild conditions and high stereoselectivity for pharmaceutical supply chains.
Patent CN100422145C reveals a green aqueous method for amide sulfone and N-substituted imine production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108947948B reveals a green one-pot synthesis for N-aryl naphthofuranone imines. Discover cost-effective manufacturing and high-purity dye intermediates.
Patent CN102612507A reveals a diimine hydrogenation process for artemisinin intermediates, offering cost reduction and high stereoselectivity for pharmaceutical manufacturing.
Patent CN116041354A reveals a mild palladium-catalyzed [5+3] cycloaddition for high-purity heterocyclic intermediates, offering significant cost reduction in API manufacturing.
Patent CN116041354A details a novel Pd-catalyzed [5+3] reaction for heterocycles, offering cost reduction and high enantioselectivity for pharma supply chains.
Patent CN1013113B details a novel route for N-(thiophen-3-yl)-chloroacetamide precursors. This method offers cost reduction in herbicide manufacturing via efficient cyclization.
Novel gold-catalyzed synthesis of indanone imine derivatives with potent anti-tumor activity. Efficient route for API intermediates ensuring cost reduction and supply stability.
Patent CN101180263B reveals a novel 3-step synthesis eliminating dimer impurities. Discover cost-effective manufacturing and stable salt forms for neurodegenerative disease therapeutics.
Patent CN110885313B reveals a novel base-mediated route to antibacterial tetraphenylpyrazoles. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN119039223B reveals a high-yield route for nitrogen-containing heteroaromatic derivatives. Discover cost reduction in API manufacturing and scalable supply solutions.
Patent CN101801984A details novel chiral phosphoramides and N-phosphonimines. Discover stable alternatives to N-sulfinylimines for cost-effective asymmetric synthesis.
Patent CN108504701A details enzymatic synthesis of metolachlor intermediate offering high purity and scalable production for reliable agrochemical intermediate supply chains.
Discover the patented protic solvent method for producing high-purity ketimines. A cost-effective, scalable solution for pharmaceutical intermediate manufacturing.
Patent CN111072515B reveals a green continuous flow method for cephalosporin intermediates, offering significant cost reduction and supply chain stability for global pharma manufacturers.
Patent CN113121403B reveals a metal-free one-step method for trisubstituted indoles. Discover cost reduction in API manufacturing and scalable production insights.
Patent CN113121619B discloses mild glycosylation using Kass reagent. Achieve high yield, stereoselective phenolic glycosides for reliable pharmaceutical intermediate supply.